BPC-157 · 5 MG Recuperación de Músculos y Tejidos

BPC-157 SYNTEX LABS: RECUPERACIÓN Y REPARACIÓN TISULAR AVANZADA PARA ATLETAS DE ALTO RENDIMIENTO

Lleva tu recuperación al siguiente nivel con BPC-157, el péptido de investigación de Syntex Labs que está redefiniendo el potencial de la reparación de tejidos.

Formulado para atletas de alto rendimiento, fisicoculturistas y cualquier persona que busque una recuperación superior de músculos, tendones y ligamentos, BPC-157 actúa como un potente modulador de la respuesta inflamatoria y promotor de la angiogénesis . Estimula la formación de nuevos vasos sanguíneos (angiogénesis) y regula las citoquinas proinflamatorias, acelerando el proceso de reparación y permitiéndote volver a tu entrenamiento con mayor rapidez y eficacia .

Experimenta la diferencia de un péptido de Grado de Laboratorio de Syntex Labs, una marca con más de una década de innovación en bioquímica en Singapur. Cada lote cuenta con trazabilidad QR y un sistema de seguridad "Scratch to See Batch Number" que garantiza la autenticidad y pureza del producto. BPC-157 es la elección de los pioneros en investigación para construir protocolos de recuperación y longevidad.

Accelerated Tissue Repair: In preclinical models, BPC-157 has demonstrated the ability to improve functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bone injuries . Inflammation Modulation: It helps normalize the post-injury inflammatory response, reducing inflammatory cytokines and protecting tissue from further damage . Angiogenesis Promotion: It stimulates the formation of new blood vessels (angiogenesis), a crucial process for delivering oxygen and nutrients to damaged tissue and accelerating healing . Gastrointestinal Tissue Regeneration: In addition to its function in the musculoskeletal system, BPC-157 supports the integrity and repair of gastrointestinal tissue, improving overall health and absorption . Improved Training Adaptation: By reducing recovery time, it allows for greater frequency and intensity in training, enhancing overall physical performance.

BPC-157 (Body Protection Compound-157) is a synthetic peptide that acts at a molecular level by activating key signaling pathways, such as the vascular endothelial growth factor receptor 2 (VEGFR2) and extracellular signal-regulated kinases (ERK1 and ERK2) . These pathways are fundamental for cellular proliferation, fibroblast migration, and new blood vessel formation. Additionally, it modulates nitric oxide (NO) production, improving endothelial function and blood flow in ischemic tissues . This combination of actions makes it a comprehensive agent for injury recovery and maintaining musculoskeletal health.

Route of Administration: Injectable via subcutaneous (SC). Reconstitution: The product is presented as a lyophilized powder in a vial. It must be reconstituted with bacteriostatic water for injection (according to research protocol instructions) before use. Research Protocol: Dosage and frequency must be determined by the researcher according to protocol goals. It is generally administered in cycles of 2 to 8 weeks to observe reported changes. Storage: Store in a cool, dry place, protected from light. Once reconstituted, refrigerate. Important Notice: Product intended EXCLUSIVELY FOR SCIENTIFIC RESEARCH.

Active Ingredient: BPC-157 (Body Protection Compound-157): A synthetic 15-amino acid peptide (sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) that is the core of the formulation. It is responsible for all the tissue repair and recovery effects observed in preclinical studies. Excipients: Mannitol: A sugar alcohol that acts as a cryoprotectant and bulking agent, used to stabilize the peptide structure during the lyophilization process, ensuring the product remains stable and retains its potency. Water for Injection (WfI): High-purity water used as a vehicle in the lyophilization process to create the sterile powder. The vial contains the lyophilized powder that must be reconstituted with an appropriate diluent (such as bacteriostatic water) before use in research. Note for Consumers: This product is a high-purity (&gt;99%) synthetic peptide, manufactured without unnecessary additives, preservatives, or fillers. Its simple and specific composition is designed for precise research and protocol reproducibility.

For researchers and high-performance athletes seeking to understand timelines, current evidence (preclinical and observational reports) suggests the following progression for BPC-157: Onset of Action (1-2 Weeks): Initial effects are often reported within the first to second week of administration. This typically manifests as a noticeable reduction in inflammation and decreased pain in the injured tissue . This early phase is believed to be related to the modulation of the acute inflammatory response. Measurable Benefits (3-6 Weeks): Significant tissue repair and structural changes begin to become observable in this period. For injuries like muscle strains, functional improvement might be expected between weeks 4 and 6 . Animal studies have shown accelerated tendon repair at approximately 2 weeks compared to control groups, but human timelines for complete functional recovery are more extensive . Full Effect (8-12 Weeks): For chronic conditions or more severe soft tissue injuries, the complete therapeutic effect and tissue remodeling often require 8 to 12 weeks of consistent use according to the research protocol . Tissue remodeling (strengthening and organizing new collagen) can continue even after the active protocol ends. Ongoing Clinical Research: A Phase 2 clinical trial (NCT07437547) is underway in 2026 to evaluate the efficacy of BPC-157 in repairing acute grade II muscle tears in athletes. This study will provide data on dosing and recovery timelines, with results expected in 2026-2027 . Influencing Factors: The speed and magnitude of results depend on the severity and type of injury, the age and health of the individual, nutritional status, sleep quality, and adherence to the research protocol

Current scientific evidence on BPC-157, up to 2026, is based primarily on preclinical studies in animal models, which show promising results in tissue repair . A 2025 systematic review identified 36 relevant studies, of which 35 were preclinical and only one was a retrospective clinical study in humans . This study showed that 7 out of 12 patients with chronic knee pain experienced relief for more than 6 months after a single intra-articular injection of BPC-157 . Currently, a Phase 2, randomized, placebo-controlled clinical trial (NCT07437547) is underway to evaluate the efficacy of BPC-157 in repairing acute grade II muscle tears in athletes, with results expected in 2026-2027 . Syntex Labs Standards: Lab Grade: Each product is manufactured under strict quality controls to ensure ≥99% purity. QR Tracking: Complete traceability of the production batch to guarantee its origin and authenticity. Secure Batch Label: &quot;Scratch to See&quot; security system that protects the product&#039;s integrity and verifies its authenticity. 3rd Party Results: Syntex Labs allows access to third-party Certificates of Analysis (COA) to verify the purity and potency of the product upon request.

Product Details

BPC-157 · 5 MG Recuperación de Músculos y Tejidos

BPC-157 · 5 MG Recuperación de Músculos y Tejidos

Build Your Stack

Frequently Asked Questions